COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,249 Articles (22,733 medRxiv, 8,516 bioRxiv)

Most recent first Previous |  Page 2120: Articles 21191-21200  | Next

A genome-wide CRISPR/Cas9 knock-out screen identifies the DEAD box RNA helicase DDX42 as a broad antiviral inhibitor
Bonaventure, B., Rebendenne, A., Garcia de Gracia, F., Tauziet, M., McKellar, J., Chaves Valadao, A. L., Courgnaud, V., Bernard, E., Briant, L., Gros, N., Djilli, W., Arnaud-Arnould, M., Parrinello, H., Rialle, S., Moncorge, O., Goujon, C.
10.1101/2020.10.28.359356 — Posted: 2020-10-28
Induced pulmonary comorbidities render CD-1 mice sensitive to SARS-CoV-2
Falach, R., Bar-On, L., Lazar, S., Kadar, T., Mazor, O., Aftalion, M., Gur, D., Shifman, O., Israeli, O., Cohen-Gihon, I., Zaida, G., Gutman, H., Evgy, Y., Vagima, Y., Makdasi, E., Stein, D., Rosenfeld, R., Alcalay, R., Zahavy, E., Levy, H., Glinert, I., Ben-Shmuel, A., Israely, T., Melamed, S., Politi, B., Achdout, H., Yitzhaky, S., Kronman, C., Sabo, T.
10.1101/2020.10.28.358614 — Posted: 2020-10-28
COVID-19 Disease Map, a computational knowledge repository of SARS-CoV-2 virus-host interaction mechanisms
Ostaszewski, M., Niarakis, A., Mazein, A., Kuperstein, I., Phair, R., Orta-Resendiz, A., Singh, V., Aghamiri, S. S., Acencio, M. L., Glaab, E., Ruepp, A., Fobo, G., Montrone, C., Brauner, B., Frishman, G., Monraz Gomez, L. C., Somers, J., Hoch, M., Gupta, S. K., Scheel, J., Borlinghaus, H., Czauderna, T., Schreiber, F., Montagud, A., Ponce de Leon, M., Funahashi, A., Hiki, Y., Hiroi, N., Yamada, T. G., Drager, A., Renz, A., Naveez, M., Bocskei, Z., Messina, F., Bornigen, D., Fergusson, L., Conti, M., Rameil, M., Nakonecnij, V., Vanhoefer, J., Schmiester, L., Wang, M., Ackerman, E. E., Shoemaker, J. E., Zucker, J., Oxford, K. L., Teuton, J., Kocakaya, E., Summak, G. Y., Hanspers, K., Kutmon, M., Coort, S., Eijssen, L., Ehrhart, F., D. A. B., R., Slenter, D., Martens, M., Haw, R., Jassal, B., Matthews, L., Orlic-Milacic, M., Senff-Ribeiro, A., Rothfels, K., Shamovsky, V., Stephan, R., Sevilla, C., Varusai, T. M., Ravel, J.-M., Fraser, R., Ortseifen, V., Marchesi, S., Gawron, P., Smula, E., Heirendt, L., Satagopam, V., Wu, G., Riutta, A., Golebiewski, M., Owen, S., Goble, C., Hu, X., Overall, R., Maier, D., Bauch, A., Bachman, J. A., Gyori, B. M., Vega, C., Groues, V., Vazquez, M., Porras, P., Licata, L., Iannuccelli, M., Sacco, F., Turei, D., Luna, A., Babur, O., Soliman, S., Valdeolivas, A., Esteban-Medina, M., Pena-Chilet, M., Helikar, T., Puniya, B. L., Nesterova, A., Yuryev, A., de Waard, A., Modos, D., Treveil, A., Olbei, M. L., De Meulder, B., Naldi, A., Dugourd, A., Noel, V., Calzone, L., Sander, C., Demir, E., Korcsmaros, T., Freeman, T. C., Auge, F., Beckmann, J. S., Hasenauer, J., Wolkenhauer, O., Willighagen, E., Pico, A. R., Evelo, C., Gillespie, M., Stein, L. D., Hermjakob, H., D'Eustachio, P., Saez-Rodriguez, J., Dopazo, J., Valencia, A., Kitano, H., Barillot, E., Auffray, C., Balling, R., Schneider, R., the COVID-19 Disease Map Community
10.1101/2020.10.26.356014 — Posted: 2020-10-28
Evaluation of the Abbott Architect, Roche Elecsys and Virtus S1 SARS-CoV-2 antibody tests in community-managed COVID-19 cases
Johnston, S. L., McKay, P. F., Kebadze, T., Hu, K., Samnuan, K., Aniscenko, J., Cameron, A., Patel, N., Randell, P., Shattock, R. J., Edwards, M. R.
10.1101/2020.10.27.20220509 — Posted: 2020-10-28
Characteristics and outcome profile of Hospitalized African COVID-19 patients: The Ethiopian Context
Leulseged, T. W., Hassen, I. S., Maru, E. H., Zewdie, W. C., Chamiso, N. W., Bayisa, A. B., Abebe, D. S., Ayele, B. T., Yegle, K. T., Edo, M. G., Gurara, E. K., Damete, D. D., Tolera, Y. A.
10.1101/2020.10.27.20220640 — Posted: 2020-10-28
Early Tocilizumab Dosing is Associated with Improved Survival In Critically Ill Patients Infected With Sars-CoV-2
Petrak, R., Van Hise, N., Skorodin, N., Fliegelman, R., Chundi, V., Didwania, V., Han, A., Harting, B., Hines, D.
10.1101/2020.10.27.20211433 — Posted: 2020-10-28
Prevalence and outcomes of co-infection and super-infection with SARS-CoV-2 and other pathogens: A Systematic Review and Meta-analysis
Musuuza, J. S., Watson, L., Parmasad, V., Putman-Buehler, N., Christensen, L., Safdar, N.
10.1101/2020.10.27.20220566 — Posted: 2020-10-28
Pandemic impacts on healthcare utilisation: a systematic review
Moynihan, R., Sanders, S., Michaleff, Z. A., Scott, A., Clark, J., To, E. J., Jones, M., Kitchener, E., Fox, M., Johansson, M., Lang, E., Duggan, A., Scott, I., Albarqouni, L.
10.1101/2020.10.26.20219352 — Posted: 2020-10-28
Corona-Independent Excess Mortality Due to Reduced Use of Emergency Medical Care in the Corona Pandemic: A Population-Based Observational Study
Kortuem, S. O., Frey, P., Becker, D., Ott, H.-J., Schlaudt, H.-P.
10.1101/2020.10.27.20220558 — Posted: 2020-10-28
Modelling trachoma post 2020: Opportunities for mitigating the impact of COVID-19 and accelerating progress towards elimination.
Borlase, A., Blumberg, S., Callahan, E. K., Deiner, M. S., Nash, S. D., Porco, T. C., Solomon, A. W., Lietman, T. M., Prada, J. M., Hollingsworth, T. D.
10.1101/2020.10.27.20219618 — Posted: 2020-10-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).